Compare, Analyse Unichem Lab with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 UNICHEM LAB   ACTAVIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
ACTAVIS
Dec-18
UNICHEM LAB/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs29213,729-   
Low Rs1829,209-   
Sales per share (Unadj.) Rs167.73,367.7-  
Earnings per share (Unadj.) Rs-3.6-1,084.7-  
Cash flow per share (Unadj.) Rs5.9354.9-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.70-  
Book value per share (Unadj.) Rs372.313,890.1-  
Shares outstanding (eoy) m70.38332.60-   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.43.4 41.5%   
Avg P/E ratio x-65.3-10.6 617.4%  
P/CF ratio (eoy) x39.932.3 123.4%  
Price / Book Value ratio x0.60.8 77.1%  
Dividend payout %-110.20-   
Avg Mkt Cap Rs m16,6803,814,612 0.4%   
No. of employees `0002.616.9 15.4%   
Total wages/salary Rs m2,3930-   
Avg. sales/employee Rs Th4,535.266,277.4 6.8%   
Avg. wages/employee Rs Th919.80-   
Avg. net profit/employee Rs Th-98.2-21,348.0 0.5%   
INCOME DATA
Net Sales Rs m11,8011,120,088 1.1%  
Other income Rs m98421,420 4.6%   
Total revenues Rs m12,7851,141,507 1.1%   
Gross profit Rs m-83529,352 -2.8%  
Depreciation Rs m674478,813 0.1%   
Interest Rs m7564,635 0.1%   
Profit before tax Rs m-600-492,677 0.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m0125,652 0.0%   
Tax Rs m-343-6,244 5.5%   
Profit after tax Rs m-256-360,781 0.1%  
Gross profit margin %-7.12.6 -270.0%  
Effective tax rate %57.31.3 4,519.4%   
Net profit margin %-2.2-32.2 6.7%  
BALANCE SHEET DATA
Current assets Rs m20,384459,401 4.4%   
Current liabilities Rs m5,029406,402 1.2%   
Net working cap to sales %130.14.7 2,750.0%  
Current ratio x4.11.1 358.6%  
Inventory Days Days10520 534.9%  
Debtors Days Days13566 203.4%  
Net fixed assets Rs m9,023126,788 7.1%   
Share capital Rs m1410-   
"Free" reserves Rs m26,0580-   
Net worth Rs m26,1994,619,838 0.6%   
Long term debt Rs m01,626,813 0.0%   
Total assets Rs m31,4967,221,859 0.4%  
Interest coverage x-7.0-6.6 105.3%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.40.2 241.6%   
Return on assets %-0.6-4.1 14.0%  
Return on equity %-1.0-7.8 12.5%  
Return on capital %-2.0-4.8 41.3%  
Exports to sales %69.40-   
Imports to sales %00-   
Net fx Rs m7,5920-   
CASH FLOW
From Operations Rs m-3,278400,165 -0.8%  
From Investments Rs m-2,860219,839 -1.3%  
From Financial Activity Rs m-24-686,803 0.0%  
Net Cashflow Rs m-4,690-66,466 7.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 70.95 Rs / USD

Compare UNICHEM LAB With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare UNICHEM LAB With: PANACEA BIOTECH  IPCA LABS  ELDER PHARMA  PIRAMAL ENTERPRISES  SHASUN PHARMA  



Today's Market

September Quarter Results, IPO Buzz, and Top Stocks in Action Today(Pre-Open)

On Wednesday, Indian share markets traded rangebound throughout the day and ended marginally higher. The BSE Sensex closed higher by 95 points to end above 39,000-mark.

Related Views On News

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound (Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

Two Stocks to Buy in the Great Indian Festival (Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

5 Smart Money Stocks to Profit from the Market Rebound (The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

My Top 10 Stocks for Accelerated Profits

Oct 18, 2019

Equitymaster's co-head of research and editor of Microcap Millionaires, Rahul Shah, talks to us about his market-beating system and his 10 best stocks to buy now. Listen in...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Oct 23, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 8-QTR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS